TRAX – first tracks biotherapeutics, inc. - ordinary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

TRAX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

7/10

01:36 pm

trax

TRAX Stock Hits All-Time High — What's Driving The Super Rally? [Yahoo! Finance]

Low Report

TRAX Stock Hits All-Time High — What's Driving The Super Rally? [Yahoo! Finance]

Report

7/10

09:00 am

trax

First Tracks Biotherapeutics (TRAX) was given a new $44.00 price target by HC Wainwright.

High Report

First Tracks Biotherapeutics (TRAX) was given a new $44.00 price target by HC Wainwright.

Report

7/8

09:57 am

trax

First Tracks Biotherapeutics (TRAX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $30.00 price target on the stock.

Low Report

First Tracks Biotherapeutics (TRAX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $30.00 price target on the stock.

Report

6/9

07:33 am

trax

First Tracks Biotherapeutics (TRAX) was upgraded by Wells Fargo & Company to "strong-buy".

Low Report

First Tracks Biotherapeutics (TRAX) was upgraded by Wells Fargo & Company to "strong-buy".

Report

6/8

07:00 am

trax

First Tracks Biotherapeutics (TRAX) is now covered by Wells Fargo & Company. They set an "overweight" rating on the stock.

Medium Report

First Tracks Biotherapeutics (TRAX) is now covered by Wells Fargo & Company. They set an "overweight" rating on the stock.

Report

5/21

04:43 pm

trax

First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences [Yahoo! Finance]

Low Report

First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences [Yahoo! Finance]

Report

5/21

04:15 pm

trax

First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences

Low Report

First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences

Report

5/14

04:15 pm

trax

First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

Medium Report

First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

Report

5/6

04:16 am

trax

First Tracks: Huge Cash Reserves Will Not Sustain Testing For Long [Seeking Alpha]

Low Report

First Tracks: Huge Cash Reserves Will Not Sustain Testing For Long [Seeking Alpha]

Report

4/29

06:34 am

trax

First Tracks Biotherapeutics (TRAX) was upgraded by Zacks Research to "hold".

High Report

First Tracks Biotherapeutics (TRAX) was upgraded by Zacks Research to "hold".

Report

4/29

06:34 am

trax

First Tracks Biotherapeutics (TRAX) was upgraded by HC Wainwright to "strong-buy".

High Report

First Tracks Biotherapeutics (TRAX) was upgraded by HC Wainwright to "strong-buy".

Report

4/28

08:00 am

trax

First Tracks Biotherapeutics (TRAX) is now covered by HC Wainwright. They set a "buy" rating and a $30.00 price target on the stock.

High Report

First Tracks Biotherapeutics (TRAX) is now covered by HC Wainwright. They set a "buy" rating and a $30.00 price target on the stock.

Report

4/24

09:00 am

trax

First Tracks Biotherapeutics (TRAX) is now covered by Leerink Partners. They set an "outperform" rating and a $46.00 price target on the stock.

High Report

First Tracks Biotherapeutics (TRAX) is now covered by Leerink Partners. They set an "outperform" rating and a $46.00 price target on the stock.

Report

4/24

09:00 am

trax

First Tracks Biotherapeutics (TRAX) is now covered by Wedbush. They set an "outperform" rating and a $30.00 price target on the stock.

High Report

First Tracks Biotherapeutics (TRAX) is now covered by Wedbush. They set an "outperform" rating and a $30.00 price target on the stock.

Report

4/23

08:00 am

trax

First Tracks Biotherapeutics (TRAX) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $31.00 price target on the stock.

Medium Report

First Tracks Biotherapeutics (TRAX) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $31.00 price target on the stock.

Report

4/22

08:00 am

trax

First Tracks Biotherapeutics (TRAX) is now covered by Barclays PLC. They set an "overweight" rating and a $40.00 price target on the stock.

Medium Report

First Tracks Biotherapeutics (TRAX) is now covered by Barclays PLC. They set an "overweight" rating and a $40.00 price target on the stock.

Report

4/21

08:00 am

trax

First Tracks Biotherapeutics (TRAX) is now covered by UBS Group AG. They set a "buy" rating and a $45.00 price target on the stock.

Medium Report

First Tracks Biotherapeutics (TRAX) is now covered by UBS Group AG. They set a "buy" rating and a $45.00 price target on the stock.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.